ロード中...
Current Treatment Options for Local Residual Nasopharyngeal Carcinoma
Local residual disease occurs in 7-13 % after primary treatment for nasopharyngeal carcinoma (NPC). To prevent tumor progression and/or distant metastasis, treatment is indicated. Biopsy is the “gold standard” for diagnosing residual disease. Because late histological regression frequently is seen a...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3841576/ https://ncbi.nlm.nih.gov/pubmed/24243165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-013-0261-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|